Protecting Your Pathology: Cybersecurity for Digital Workflows
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Expert Q&A: Harnessing the Power of AI
AI could help pathologists manage increasing workloads amid staffing shortages—if only they take the leap.
Surviving a Cyberattack
When it comes to cyberattacks, the threat is “when,” not “if”—and labs must be prepared to mitigate, contain, and recover from breaches
FDA Watch: Expanded Label Clearance Opens Cologuard to a Younger Market
September was an eventful month for one of the hottest products on the consumer genetic test market, the Cologuard multi-target stool DNA test (mtSDNA) for colorectal cancer screening produced by Exact Sciences. The month started badly with the release of a CMS-sponsored research report finding Cologuard “less effective and considerably more costly” than alternatives. Although Exact Sciences quickly criticized the report and its analytical methodology, its stock took a beating.
Laboratory Information Systems (LIS): What You Need To Know To Get Paid
By Sean McSweeney bio
Today, laboratory billing claims require more and more data to successfully get paid.
One of the biggest reasons your claims may be getting denied is because…
Inside the Diagnostics Industry: New Government BRCA Test Guidelines Are a Mixed Bag for Genetic Testing Labs
From - Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…